Rian Dickstein, MD, Named Cancer Physician Liaison for Baltimore Washington Medical Center’s Tate Cancer Center

Published On: 05/05/2015

Rian J. Dickstein, M.D., urologic oncologist with Chesapeake Urology, has been named the Cancer Physician Liaison for The University of Maryland Baltimore Washington Medical Center’s Tate Cancer Center, serving as the liaison between BWMC’s cancer program, the Commission on Cancer (CoC) and the American Cancer Society. In this role, Dr. Dickstein will work with the medical center’s multidisciplinary cancer team to evaluate, interpret and report the program’s performance using National Cancer Data Base (NCDB) data to the cancer committee as well as establish best practices for improving the quality of care. As Cancer Physician Liaison, Dr. Dickstein will also work with local agencies and The American Cancer Society on community outreach programs and education.

The Cancer Liaison Program of the Commission on Cancer was established in 1963 as a grassroots network of physician volunteers willing to manage clinically related cancer activities in their local hospitals and surrounding communities. The CoC was established by the American College of Surgeons to develop standards that ensure quality, multidisciplinary and comprehensive cancer care delivery in healthcare settings.

Dr. Dickstein is a urologic oncologist who trained at the world-renowned MD Anderson Cancer Center in Houston, Texas. He focuses on all urologic cancers and specializes in open, laparoscopic and robotic surgeries. His expertise includes the treatment of bladder cancer (non-invasive and locally advanced), kidney cancer (small or locally advanced tumors), and prostate cancer, including primary and salvage surgery for complex cases.